In this program, we review a patient case to understand the intensification of therapy beyond basil insulin.
This program is estimated at 0.25 hour(s) of interactive online continuing health education.
|David C.W. Lau(MD, PhD, FRCPC)|
David Strain(MB, ChB, BSc (Hons) MD, FRCP)
Deanna Telner(MD, CCFP)
Elizabeth Rosolowsky(MD, MPH, FAAP, FRCPC)
Filip K. Knop(MD, PhD)
Jeffrey Habert(MD, CCFP, FCFP)
John Axler(MD, CCFP, FCFP)
Peter J. Lin(MD, CCFP)
Robyn L. Houlden(MD, FRCPC)
Thomas Round(MBBS, BSc, DRCOG, MRCGP)
Upon completion of this program, participants will be able to:
- Review when to consider intensification in therapy in a patient with type 2 diabetes on basal insulin
- Examine the different therapy options clinicians can consider adding to basal insulin therapy in type 2 diabetes